Saori Sakaue, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 33 | 2024 | 12264 | 1.570 |
Why?
|
Multifactorial Inheritance | 6 | 2022 | 1194 | 1.130 |
Why?
|
Genetic Predisposition to Disease | 19 | 2024 | 17449 | 1.020 |
Why?
|
Japan | 14 | 2023 | 1361 | 0.960 |
Why?
|
HLA Antigens | 3 | 2023 | 1382 | 0.860 |
Why?
|
Biological Specimen Banks | 3 | 2021 | 712 | 0.760 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2021 | 42 | 0.760 |
Why?
|
Multifactor Dimensionality Reduction | 1 | 2020 | 10 | 0.750 |
Why?
|
Alcohol Dehydrogenase | 1 | 2019 | 119 | 0.680 |
Why?
|
Polymorphism, Single Nucleotide | 21 | 2024 | 15525 | 0.660 |
Why?
|
Arthritis, Rheumatoid | 4 | 2022 | 3712 | 0.660 |
Why?
|
Genetics, Population | 2 | 2021 | 934 | 0.640 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 902 | 0.600 |
Why?
|
Drug Repositioning | 1 | 2019 | 229 | 0.600 |
Why?
|
Graves Disease | 1 | 2018 | 242 | 0.580 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1366 | 0.580 |
Why?
|
Takayasu Arteritis | 1 | 2016 | 96 | 0.510 |
Why?
|
Genome, Human | 6 | 2023 | 4420 | 0.510 |
Why?
|
Exophthalmos | 1 | 2015 | 97 | 0.480 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2014 | 41 | 0.470 |
Why?
|
Major Histocompatibility Complex | 4 | 2021 | 936 | 0.470 |
Why?
|
Genetic Markers | 1 | 2020 | 2634 | 0.460 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2702 | 0.450 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 645 | 0.450 |
Why?
|
Autoimmune Diseases | 2 | 2023 | 2136 | 0.430 |
Why?
|
Autoantibodies | 1 | 2021 | 2038 | 0.430 |
Why?
|
Longevity | 1 | 2020 | 1069 | 0.420 |
Why?
|
Gene Regulatory Networks | 3 | 2020 | 1708 | 0.410 |
Why?
|
Genome | 1 | 2019 | 1808 | 0.380 |
Why?
|
Body Height | 3 | 2022 | 1576 | 0.380 |
Why?
|
Genetic Loci | 5 | 2021 | 2575 | 0.320 |
Why?
|
Asthma | 2 | 2018 | 6011 | 0.320 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.310 |
Why?
|
Alleles | 7 | 2023 | 6938 | 0.300 |
Why?
|
MicroRNAs | 2 | 2022 | 3747 | 0.280 |
Why?
|
Colitis, Ulcerative | 1 | 2018 | 1912 | 0.280 |
Why?
|
Quantitative Trait Loci | 4 | 2023 | 2019 | 0.280 |
Why?
|
Gene Frequency | 6 | 2022 | 3588 | 0.260 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 1339 | 0.240 |
Why?
|
Haplotypes | 4 | 2023 | 2781 | 0.240 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 182 | 0.230 |
Why?
|
Phenotype | 10 | 2022 | 16365 | 0.220 |
Why?
|
Genomics | 5 | 2022 | 5722 | 0.200 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 967 | 0.200 |
Why?
|
Physical Chromosome Mapping | 1 | 2021 | 183 | 0.200 |
Why?
|
Linkage Disequilibrium | 6 | 2022 | 1997 | 0.200 |
Why?
|
Selection, Genetic | 3 | 2021 | 914 | 0.190 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 162 | 0.180 |
Why?
|
Amino Acids | 2 | 2023 | 1734 | 0.180 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2021 | 380 | 0.180 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1344 | 0.170 |
Why?
|
ABO Blood-Group System | 1 | 2021 | 367 | 0.170 |
Why?
|
Finland | 1 | 2020 | 602 | 0.160 |
Why?
|
Chromosomes, Human | 1 | 2020 | 457 | 0.160 |
Why?
|
Humans | 42 | 2024 | 744220 | 0.150 |
Why?
|
Chromosome Mapping | 2 | 2024 | 4742 | 0.150 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.140 |
Why?
|
Genetic Variation | 3 | 2021 | 6546 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 1940 | 0.140 |
Why?
|
Protein Isoforms | 1 | 2021 | 1731 | 0.140 |
Why?
|
Dental Caries | 1 | 2019 | 415 | 0.130 |
Why?
|
Genotype | 4 | 2023 | 12956 | 0.130 |
Why?
|
Hypertension | 3 | 2020 | 8480 | 0.130 |
Why?
|
Chromatin | 2 | 2023 | 2934 | 0.130 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 817 | 0.120 |
Why?
|
Periodontitis | 1 | 2019 | 553 | 0.120 |
Why?
|
Organ Specificity | 1 | 2018 | 2007 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1161 | 0.120 |
Why?
|
Case-Control Studies | 3 | 2021 | 21752 | 0.120 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2016 | 595 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 12075 | 0.110 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2170 | 0.110 |
Why?
|
Female | 19 | 2023 | 380197 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.110 |
Why?
|
Disease | 1 | 2018 | 681 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 933 | 0.100 |
Why?
|
Forecasting | 2 | 2017 | 2949 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2020 | 2563 | 0.100 |
Why?
|
Rheumatic Diseases | 1 | 2017 | 593 | 0.090 |
Why?
|
Eye | 1 | 2015 | 729 | 0.090 |
Why?
|
Prednisone | 1 | 2015 | 1575 | 0.090 |
Why?
|
Eosinophils | 1 | 2015 | 956 | 0.090 |
Why?
|
Computational Biology | 2 | 2018 | 3523 | 0.090 |
Why?
|
Drug Discovery | 1 | 2017 | 1058 | 0.080 |
Why?
|
Male | 15 | 2023 | 350027 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1939 | 0.080 |
Why?
|
Base Sequence | 1 | 2020 | 12801 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9685 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2019 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7799 | 0.080 |
Why?
|
Psoriasis | 1 | 2016 | 898 | 0.080 |
Why?
|
Middle Aged | 8 | 2021 | 213367 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 11732 | 0.070 |
Why?
|
Adult | 9 | 2022 | 214035 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.070 |
Why?
|
Stroke | 2 | 2020 | 9981 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3966 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9438 | 0.070 |
Why?
|
Risk Factors | 4 | 2020 | 72280 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2024 | 4645 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2279 | 0.070 |
Why?
|
Software | 1 | 2019 | 4442 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 7022 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1789 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3079 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4559 | 0.060 |
Why?
|
Aged | 6 | 2021 | 163253 | 0.060 |
Why?
|
Qc-SNARE Proteins | 1 | 2023 | 21 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18367 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4044 | 0.050 |
Why?
|
Biopsy | 1 | 2015 | 6757 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1782 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4556 | 0.050 |
Why?
|
Lipids | 2 | 2022 | 3305 | 0.050 |
Why?
|
Population Groups | 1 | 2021 | 209 | 0.050 |
Why?
|
Chromosomes | 1 | 2023 | 596 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6489 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2020 | 142 | 0.040 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2019 | 31 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2023 | 794 | 0.040 |
Why?
|
Genetics | 1 | 2020 | 112 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8037 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 846 | 0.040 |
Why?
|
Heredity | 1 | 2019 | 154 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1107 | 0.040 |
Why?
|
RNA, Untranslated | 1 | 2022 | 454 | 0.040 |
Why?
|
Tokyo | 1 | 2018 | 22 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13885 | 0.040 |
Why?
|
Hominidae | 1 | 2018 | 74 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2020 | 340 | 0.040 |
Why?
|
Railroads | 1 | 2018 | 62 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2022 | 839 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12742 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1119 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29784 | 0.040 |
Why?
|
Medical History Taking | 1 | 2020 | 783 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
Markov Chains | 1 | 2020 | 969 | 0.040 |
Why?
|
Genetic Research | 1 | 2017 | 174 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15161 | 0.030 |
Why?
|
Europe | 1 | 2022 | 3339 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23404 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 16718 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10396 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2453 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57768 | 0.030 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 1005 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21672 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1860 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3300 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2586 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2022 | 2915 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2020 | 4201 | 0.020 |
Why?
|
Employment | 1 | 2018 | 1129 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2069 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2305 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56436 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3558 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35423 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3494 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85759 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3598 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3646 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15999 | 0.020 |
Why?
|
Depression | 1 | 2024 | 7767 | 0.010 |
Why?
|
HIV-1 | 1 | 2021 | 6938 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8661 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12805 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12207 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23337 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 25618 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40559 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25043 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40063 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35129 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 40992 | 0.010 |
Why?
|
United States | 1 | 2021 | 69867 | 0.010 |
Why?
|
Child | 1 | 2018 | 77679 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168788 | 0.000 |
Why?
|